← Browse by Condition
Medical Condition
helicobacter pylori infection
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 3, Phase 2
ClinicalMetric tracks all active clinical trials for helicobacter pylori infection sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — helicobacter pylori infection Clinical Trials
How many clinical trials are currently recruiting for helicobacter pylori infection?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for helicobacter pylori infection, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for helicobacter pylori infection?
helicobacter pylori infection research spans Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a helicobacter pylori infection clinical trial?
Eligibility criteria for helicobacter pylori infection trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07516262
Recruiting
Effect of PPIs on Stool DNA Test for H. Pylori
Enrollment
25 pts
Location
China
Sponsor
Shanghai Jiao Tong University ...
NCT07242456 Phase 2, Phase 3
Recruiting
Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication
Enrollment
240 pts
Location
China
Sponsor
First People's Hospital of Han...
NCT06382493
Recruiting
Tegoprazan-containing Sequential for H. Pylori
Enrollment
400 pts
Location
South Korea
Sponsor
Seoul National University Bund...
NCT07439445
Recruiting
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
Enrollment
70 pts
Location
China
Sponsor
Peking University First Hospit...
NCT07358130
Recruiting
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy
Enrollment
552 pts
Location
Taiwan
Sponsor
Kaohsiung Medical University
NCT06228963 Phase 2
Recruiting
Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma
Enrollment
160 pts
Location
China
Sponsor
Fudan University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology